Login / Signup

Assessment of intramyocardial hemorrhage with dark-blood T2*-weighted cardiovascular magnetic resonance.

Xingmin GuanYinyin ChenHsin-Jung YangXinheng ZhangDaoyuan RenJane SykesJohn ButlerHui HanMengsu ZengFrank S PratoRohan Dharmakumar
Published in: Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance (2021)
While IMH can be visible on dark-blood T2*-weighted CMR, the overall conspicuity of IMH is significantly reduced compared to that observed in bright-blood T2*-weighted images, across infarct age in clinical and preclinical settings at 1.5 and 3 T. Hence, bright-blood T2*-weighted CMR would be preferable for clinical use since dark-blood T2*-weighted CMR carries the potential to misclassify hemorrhagic MIs as non-hemorrhagic MIs.
Keyphrases
  • magnetic resonance
  • contrast enhanced
  • network analysis
  • magnetic resonance imaging
  • stem cells
  • acute myocardial infarction
  • heart failure
  • mesenchymal stem cells
  • cell therapy
  • percutaneous coronary intervention